We recently published a list of the 10 Best Rising Penny Stocks to Buy According to Analysts. In this article, we are going ...

Chibi Captain Regulus and Officer Liang Yue Host Livestream With First Look of “Showdown in Chinatown” HONG KONG – APRIL 17, 2025 – The time and date have been set for the next livestream for 20th ...

Regulus Investment and Financial Services Ghana Limited has been recognized as the “Outstanding Financial Brand of the Year” ...

Regulus Therapeutics Inc.’s RGLS share price has surged by 7.85%, which has investors questioning if this is right time to ...

Tim-3, a molecule involved in immune regulation, hinders plaque removal in Alzheimer’s disease. Blocking it in microglia improved brain health in mice, making it a potential treatment target. Tim-3 is ...

New research reveals that the immune checkpoint molecule Tim-3 plays a critical role in how microglia, the brain’s immune cells, respond to Alzheimer’s disease.

Tim-3 is an immune checkpoint molecule involved in immunity and inflammation recently linked to late-onset Alzheimer's ...

While Donald Trump spared pharma companies from his tariff announcement last week, he revealed yesterday plans to announce ...

Tim-3 is an immune checkpoint molecule involved in immunity and inflammation recently linked to late-onset Alzheimer’s disease (AD), but its role in the brain was unknown until now. In a paper ...

SAN DIEGO, April 2, 2025 /PRNewswire/ -- Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company focused on the discovery and development of innovative medicines targeting microRNAs ...

Overview: Regulus Therapeutics Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing drugs targeting microRNAs to treat various diseases in the United States ...